Delivery Order SPE2DB24D1205-SPE2DB25FCYRV
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,961.64 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- This is a $2,366.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the pharmaceutical product Gadavist, a 10 milliliter vial containing 10 millimoles per milliliter. The delivery order has a completion date of June 11, 2025 and is not set aside for any small business categories. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $1,573.54, is for the supply of Gadavist 10 mmol/10 ml vial, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,083.96, is for the delivery of Gadavist 7.5 millimolar/7.5 milliliter vials. It is a firm fixed-price contract with a period of performance ending on May 5, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,828.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 mL vial of a 10 mmol/mL solution, with a performance period ending on May 6, 2025. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This is a $1,040.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to supply the drug Gadavist, a contrast agent used in medical imaging procedures. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gadavist 1 mmol/ml bulk vial (30 ml), a pharmaceutical product, at a firm fixed price of $1,704.90. The contract has an ultimate completion date of May 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,962.44, is for the supply of Gadavist, a 10 mmol/10 ml vial medication, with a period of performance through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at approximately $719 to Amerisourcebergen Drug Corporation for Gadavist, a contrast agent used in magnetic resonance imaging. To be performed over a one day period in Conshohocken, Pennsylvania, the firm fixed price contract calls for the delivery of 10 millimoles of Gadavist in 10 milliliter vials. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Gadavist 10 MMOL/10 ML vials. The award, valued at $4,315.48, is a Firm Fixed Price Delivery Order with a completion date of June 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...